Prediction of the short-term efficacy of anti-VEGF therapy for neovascular age-related macular degeneration using optical coherence tomography angiography.
Huixun JiaBing LuZhi ZhaoYang YuFenghua WangMinwen ZhouXiaodong SunPublished in: Eye and vision (London, England) (2022)
Type 2 and mixed-type NV were significantly associated with a better response to anti-VEGF therapy. Changes in GVC after 3 months of treatment were significantly associated with a response to anti-VEGF therapy at 6 months.